MetLife, Inc. (MET-PA) trades at a trailing P/E of 14.6, forward P/E of 2.2. Trailing earnings yield is 6.83%, forward earnings yield 46.30%. PEG 0.02 (Peter Lynch undervalued ≤1.0). Graham Number is $70.52.
Criteria proven by this page:
Overall SharesGrow Score: 67/100 with 4/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 61.9 | -0.77 | 0.78 | 0.87 | 3.50% |
| 2017 | 13.2 | 0.03 | 0.90 | 0.85 | 3.45% |
| 2018 | 7.7 | 0.24 | 0.75 | 0.58 | 4.62% |
| 2019 | 7.9 | 0.34 | 0.71 | 0.67 | 3.90% |
| 2020 | 7.8 | -1.24 | 0.56 | 0.62 | 4.43% |
| 2021 | 7.5 | 0.22 | 0.76 | 0.81 | 3.57% |
| 2022 | 10.7 | -0.61 | 1.89 | 0.83 | 3.16% |
| 2023 | 32.0 | -0.45 | 1.68 | 0.74 | 3.50% |
| 2024 | 12.8 | 0.06 | 2.06 | 0.81 | 3.06% |
| 2025 | 15.5 | -0.79 | 1.85 | 0.68 | 3.24% |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $0.73 | $60.73B | $850M | 1.4% |
| 2017 | $3.74 | $62.31B | $4.01B | 6.4% |
| 2018 | $5.20 | $67.94B | $5.12B | 7.5% |
| 2019 | $6.06 | $69.62B | $5.9B | 8.5% |
| 2020 | $5.68 | $67.84B | $5.41B | 8% |
| 2021 | $7.70 | $63.65B | $6.86B | 10.8% |
| 2022 | $2.91 | $67.82B | $5.28B | 7.8% |
| 2023 | $1.81 | $66.41B | $1.58B | 2.4% |
| 2024 | $5.94 | $69.9B | $4.43B | 6.3% |
| 2025 | $4.80 | $77.08B | $3.38B | 4.4% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $9.78 | $9.23 – $10.11 | $79.59B | $76.11B – $81.46B | 1 |
| 2027 | $10.93 | $10.32 – $11.30 | $83.24B | $79.17B – $85.09B | 1 |
| 2028 | $12.34 | $11.65 – $12.76 | $87.3B | $83.27B – $89.31B | 1 |
| 2029 | $12.85 | $12.13 – $13.29 | $92.26B | $88.26B – $94.67B | 1 |
